Quipt Home Medical Corp (QIPT) Peer Comparison
$3.65
$0.00 (0.00%)As on 23-Mar-2026 09:30EDT
Market cap
$162 Mln
Revenue (TTM)
$285 Mln
P/E Ratio
--
P/B Ratio
1.6
Div. Yield
0 %
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
Market cap ($ Mln) |
162 | 6,233 | 336 | 250 |
Revenue ($ Mln) |
285 | 5,319 | 302 | 19 |
Net Profit ($ Mln) |
-10.72 | -171.00 | 14.50 | -32.65 |
Net Margin (%) |
-3.76 | -3.21 | 4.81 | -171.72 |
RoE (%) |
-9.17 | -2.79 | 9.78 | -46.38 |
Price to Earnings |
-- | -- | 24.50 | -- |
Price-To-Book |
1.61 | 0.98 | 2.38 | 5.10 |
Cashflow ($ Mln)
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
|
Cash From Operating Activities
|
37.69 | 283.00 | 51.92 | -38.88 |
|
Cash Flow from Investing Activities
|
-32.95 | -455.00 | -50.17 | -0.25 |
|
Cash from Financing Activities
|
-7.76 | 225.00 | -5.79 | 41.86 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- |
Ratios
Profitability Ratios
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
|
ROCE (%)
|
-4.60 | -3.10 | 10.10 | -53.15 |
|
ROE (%)
|
-8.67 | -5.57 | 10.94 | -57.21 |
|
ROA (%)
|
-3.34 | -2.62 | 7.62 | -32.92 |
|
EBIT Margin (%)
|
-- | -- | -- | -- |
|
Net Margin (%)
|
-3.13 | -7.06 | 5.53 | -264.44 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- |
Growth Ratios
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
|
Revenue Growth (%)
|
0.39 | 0.06 | 0.21 | 0.61 |
|
EBIT Growth (%)
|
-- | -- | -- | -- |
|
Net Profit Growth (%)
|
-58.23 | -13.56 | 32.57 | -63.57 |
|
EPS Growth (%)
|
-0.57 | -0.13 | 0.37 | -0.37 |
|
Book Value Growth (%)
|
-- | -- | -- | -- |
Valuation Ratios
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
|
Price / Earnings
|
-10.60 | -16.81 | 19.98 | -5.58 |
|
Price / Book Value
|
0.81 | 0.94 | 2.11 | 2.66 |
|
Dividend Yield (%)
|
-- | -- | -- | -- |
|
EV/EBITDA
|
3.82 | 20.64 | 5.83 | -4.02 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- |
Solvency Ratios
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
|
Debt to Equity
|
0.85 | 0.83 | 0.11 | 0.07 |
|
Short term debt to equity ratio
|
0.17 | 0.01 | 0.02 | 0.00 |
|
Current Ratio
|
1.46 | 1.55 | 1.18 | 12.52 |
|
Quick Ratio
|
1.12 | 1.04 | 1.06 | 11.17 |
|
Interest Coverage
|
-0.87 | 0.26 | 19.42 | -- |
Operating Efficiency Ratios
| Quipt Home Medical Corp (QIPT) | Bausch + Lomb Corp (BLCO) | Viemed Healthcare (VMD) | Profound Medical (PROF) | |
|---|---|---|---|---|
|
Debtors to sales (%)
|
10.16 | 23.94 | 9.47 | 60.20 |
|
Asset Turnover
|
1.07 | 0.37 | 1.38 | 0.12 |
|
Receivable days
|
34.13 | 80.45 | 34.12 | 188.50 |
|
Inventory Days
|
1,402.74 | 159.20 | 14.90 | 651.71 |
|
Payable days
|
2,043.81 | 61.48 | 34.46 | 131.90 |
|
Cash Conversion Cycle
|
-606.94 | 178.17 | 14.56 | 708.30 |